Literature DB >> 22056379

T cell-driven initiation and propagation of autoimmune diabetes.

Maria Bettini1, Dario A A Vignali.   

Abstract

The destruction of beta cells in type 1 diabetes in humans and in autoimmune diabetes in the NOD mouse model is a consequence of chronic islet inflammation in the pancreas. The T cell-driven autoimmune response is initiated by environmental triggers which are influenced by the state of intestinal homeostasis and the microbiota. The disease process can be separated into two phases: firstly, initiation of mild, controlled, long-term infiltration and secondly, propagation of invasive inflammation which quickly progresses to beta cell deletion and autoimmune diabetes. In this review, we will discuss the cellular and molecular triggers that might be required for these two phases in the context of other issues including the unique anatomical location of pancreas, the location of T cell priming, the requirements for islet entry, and the events that ultimately drive beta cell destruction and the onset of diabetes.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22056379      PMCID: PMC3232326          DOI: 10.1016/j.coi.2011.10.002

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  50 in total

1.  Molecular targeting of islet autoantigens.

Authors:  Brian Stadinski; John Kappler; George S Eisenbarth
Journal:  Immunity       Date:  2010-04-23       Impact factor: 31.745

Review 2.  Posttranslational modifications of self-antigens.

Authors:  Hester A Doyle; Mark J Mamula
Journal:  Ann N Y Acad Sci       Date:  2005-06       Impact factor: 5.691

3.  Interleukin-2 gene variation impairs regulatory T cell function and causes autoimmunity.

Authors:  Jun Yamanouchi; Dan Rainbow; Pau Serra; Sarah Howlett; Kara Hunter; Valerie E S Garner; Andrea Gonzalez-Munoz; Jan Clark; Riitta Veijola; Rose Cubbon; Show-Ling Chen; Raymond Rosa; Anne Marie Cumiskey; David V Serreze; Simon Gregory; Jane Rogers; Paul A Lyons; Barry Healy; Luc J Smink; John A Todd; Laurence B Peterson; Linda S Wicker; Pere Santamaria
Journal:  Nat Genet       Date:  2007-02-04       Impact factor: 38.330

4.  CXCL13 blockade disrupts B lymphocyte organization in tertiary lymphoid structures without altering B cell receptor bias or preventing diabetes in nonobese diabetic mice.

Authors:  Rachel A Henry; Peggy L Kendall
Journal:  J Immunol       Date:  2010-06-23       Impact factor: 5.422

5.  Salmonella typhimurium infection in nonobese diabetic mice generates immunomodulatory dendritic cells able to prevent type 1 diabetes.

Authors:  Tim Raine; Paola Zaccone; Pietro Mastroeni; Anne Cooke
Journal:  J Immunol       Date:  2006-08-15       Impact factor: 5.422

6.  Cellular and molecular events in the localization of diabetogenic T cells to islets of Langerhans.

Authors:  Boris Calderon; Javier A Carrero; Mark J Miller; Emil R Unanue
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-10       Impact factor: 11.205

7.  Chromogranin A is an autoantigen in type 1 diabetes.

Authors:  Brian D Stadinski; Thomas Delong; Nichole Reisdorph; Richard Reisdorph; Roger L Powell; Michael Armstrong; Jon D Piganelli; Gene Barbour; Brenda Bradley; Frances Crawford; Philippa Marrack; Sushil K Mahata; John W Kappler; Kathryn Haskins
Journal:  Nat Immunol       Date:  2010-02-07       Impact factor: 25.606

8.  T cell islet accumulation in type 1 diabetes is a tightly regulated, cell-autonomous event.

Authors:  Greig P Lennon; Maria Bettini; Amanda R Burton; Erica Vincent; Paula Y Arnold; Pere Santamaria; Dario A A Vignali
Journal:  Immunity       Date:  2009-10-08       Impact factor: 31.745

9.  Innate immunity and intestinal microbiota in the development of Type 1 diabetes.

Authors:  Li Wen; Ruth E Ley; Pavel Yu Volchkov; Peter B Stranges; Lia Avanesyan; Austin C Stonebraker; Changyun Hu; F Susan Wong; Gregory L Szot; Jeffrey A Bluestone; Jeffrey I Gordon; Alexander V Chervonsky
Journal:  Nature       Date:  2008-09-21       Impact factor: 49.962

10.  Defects in IL-2R signaling contribute to diminished maintenance of FOXP3 expression in CD4(+)CD25(+) regulatory T-cells of type 1 diabetic subjects.

Authors:  S Alice Long; Karen Cerosaletti; Paul L Bollyky; Megan Tatum; Heather Shilling; Sheng Zhang; Zhong-Yin Zhang; Catherine Pihoker; Srinath Sanda; Carla Greenbaum; Jane H Buckner
Journal:  Diabetes       Date:  2009-10-29       Impact factor: 9.461

View more
  18 in total

Review 1.  Imaging beta-cell mass and function in situ and in vivo.

Authors:  Lu Yang; Wei Ji; Yanhong Xue; Liangyi Chen
Journal:  J Mol Med (Berl)       Date:  2013-05-23       Impact factor: 4.599

2.  Dynamic Immune Phenotypes of B and T Helper Cells Mark Distinct Stages of T1D Progression.

Authors:  Tania Habib; S Alice Long; Peter L Samuels; Archana Brahmandam; Megan Tatum; Andrew Funk; Anne M Hocking; Karen Cerosaletti; Michael T Mason; Elizabeth Whalen; David J Rawlings; Carla Greenbaum; Jane H Buckner
Journal:  Diabetes       Date:  2019-03-20       Impact factor: 9.461

3.  Coupling of Insulin Secretion and Display of a Granule-resident Zinc Transporter ZnT8 on the Surface of Pancreatic Beta Cells.

Authors:  Qiong Huang; Chengfeng Merriman; Hao Zhang; Dax Fu
Journal:  J Biol Chem       Date:  2017-01-27       Impact factor: 5.157

4.  Fasting and meal-stimulated residual beta cell function is positively associated with serum concentrations of proinflammatory cytokines and negatively associated with anti-inflammatory and regulatory cytokines in patients with longer term type 1 diabetes.

Authors:  M N Pham; H Kolb; T Battelino; J Ludvigsson; P Pozzilli; F Zivehe; M Roden; T Mandrup-Poulsen; N C Schloot
Journal:  Diabetologia       Date:  2013-03-15       Impact factor: 10.122

5.  Characterization of the peptide binding specificity of the HLA class I alleles B*38:01 and B*39:06.

Authors:  John Sidney; Jennifer Schloss; Carrie Moore; Mikaela Lindvall; Amanda Wriston; Donald F Hunt; Jeffrey Shabanowitz; Teresa P DiLorenzo; Alessandro Sette
Journal:  Immunogenetics       Date:  2016-01-11       Impact factor: 3.330

6.  Effects of Differences in Lipid A Structure on TLR4 Pro-Inflammatory Signaling and Inflammasome Activation.

Authors:  Paula M Chilton; Chelsea A Embry; Thomas C Mitchell
Journal:  Front Immunol       Date:  2012-06-13       Impact factor: 7.561

7.  Distortion of the Major Histocompatibility Complex Class I Binding Groove to Accommodate an Insulin-derived 10-Mer Peptide.

Authors:  Chihiro Motozono; James A Pearson; Evy De Leenheer; Pierre J Rizkallah; Konrad Beck; Andrew Trimby; Andrew K Sewell; F Susan Wong; David K Cole
Journal:  J Biol Chem       Date:  2015-06-17       Impact factor: 5.157

8.  Antibody combination therapy targeting CD25, CD70 and CD8 reduces islet inflammation and improves glycaemia in diabetic mice.

Authors:  T Alkhamis; J Barbic; T Crnogorac-Jurcevic; R E Greenlaw; M Peakman; S Jurcevic
Journal:  Clin Exp Immunol       Date:  2012-11       Impact factor: 4.330

9.  Non-catalytic functions of Pyk2 and Fyn regulate late stage adhesion in human T cells.

Authors:  Nicole M Chapman; Ashley N Yoder; Jon C D Houtman
Journal:  PLoS One       Date:  2012-12-27       Impact factor: 3.240

10.  Comprehensive Survey of miRNA-mRNA Interactions Reveals That Ccr7 and Cd247 (CD3 zeta) are Posttranscriptionally Controlled in Pancreas Infiltrating T Lymphocytes of Non-Obese Diabetic (NOD) Mice.

Authors:  Thais A Fornari; Paula B Donate; Amanda F Assis; Claudia Macedo; Elza T Sakamoto-Hojo; Eduardo A Donadi; Geraldo A Passos
Journal:  PLoS One       Date:  2015-11-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.